| 1 |
John Gatzemeyer |
Colgate-Palmolive |
6 |
| 2 |
Kawai Pang |
Dow Global Technologies |
2 |
| 2 |
Christophe Bucher |
As America |
2 |
| 2 |
Boris Shekunov |
Ferro |
2 |
| 2 |
Ganapathy Subramanian Sundaram |
Alcatel Lucent |
2 |
| 2 |
Shyam B. Karki |
Biogen Ma |
2 |
| 2 |
Michael Robbins |
Pfizer |
2 |
| 2 |
Hsing-Chi Yeh |
Johnson & Johnson |
2 |
| 2 |
Marie-Pierre Jolly |
Siemens Aktiengesellschaft |
2 |
| 2 |
Timothy A. Gillespy |
Aventis Pharmaceuticals |
2 |
| #11 |
Amjad Farooq |
Colgate-Palmolive |
1 |
| #11 |
Fred G. Devlin, III |
Phd |
1 |
| #11 |
Kim Vesey |
Avery Dennison |
1 |
| #11 |
Mjing Lu |
AT&T |
1 |
| #11 |
Kypros Tamanas |
— |
1 |
| #11 |
Ramaswamy Murari |
Delsys Pharmaceutical |
1 |
| #11 |
Brian Bloch |
Colgate-Palmolive |
1 |
| #11 |
David G. Belanger |
AT&T |
1 |
| #11 |
Thomas E. Chapuran |
Telcordia Technologies |
1 |
| #11 |
David Ruddock |
Baker Hughes Oilfield Operations |
1 |
| #11 |
Robert Proniewski |
Phd |
1 |
| #11 |
Rao S. Chakradhara |
Johnson & Johnson |
1 |
| #11 |
Scott Wallace |
Union Carbide |
1 |
| #11 |
Stephan Wielandy |
Lgs Innovations |
1 |
| #11 |
Vipul Dave |
Cordis |
1 |
| #11 |
Kevin Weadock |
Johnson & Johnson |
1 |
| #11 |
Kevin Michael Mitzak |
— |
1 |
| #11 |
Jeffrey Depue |
Bristol-Myers Squibb |
1 |
| #11 |
Marybeth Finnegan |
Warner-Lambert Company |
1 |
| #11 |
Sarah R. Mangee |
Man-How |
1 |
| #11 |
Glenn T. Van Lier |
Solidification Products International |
1 |
| #11 |
Gerard Gendimenico |
Johnson & Johnson |
1 |
| #11 |
Anees Karnachi |
Novartis Ag |
1 |
| #11 |
Joseph Dudash |
Johnson & Johnson |
1 |
| #11 |
James H. Simpson |
Bristol-Myers Squibb |
1 |
| #11 |
John J. D'Esposito |
IBM |
1 |
| #11 |
Raymond A. Cirelli |
AT&T |
1 |